Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour
1998

Loss of Heterozygosity on Chromosome 16 in Wilms' Tumour

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): RG Grundy, J Pritchard, P Scambler, JK Cowell

Primary Institution: Institute of Child Health, London

Hypothesis

Does loss of heterozygosity (LOH) for chromosome 16q in Wilms' tumours confer an adverse prognosis?

Conclusion

The study found that loss of heterozygosity for chromosome 16q is associated with a worse prognosis in Wilms' tumours.

Supporting Evidence

  • 15% of the tumours showed loss of heterozygosity for chromosome 16q.
  • Five out of six tumours with LOH were either high stage or low stage with unfavourable histology.
  • There was a higher mortality rate in patients showing LOH for 16q than those that did not.

Takeaway

Some kids with a type of kidney cancer called Wilms' tumour have a change in their DNA that makes it harder for them to get better.

Methodology

DNA from 40 Wilms' tumour/normal pairs was analyzed using microsatellite markers to check for loss of heterozygosity.

Limitations

The study is retrospective and based on a selected series of tumours, which may limit the generalizability of the findings.

Participant Demographics

The study involved children diagnosed with Wilms' tumour, with varying stages of the disease.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication